top of page
PRECISION CELL THERAPIES
WonderBank Holdings is advancing off-the-shelf cell therapies through a proprietary HLA-homozygous stem cell biobank designed to match more than 90% of U.S. and European patients.
Building a Scalable Cell Therapy Platform
WonderBank Holdings, founded by Ruvin Orbach, has assembled a proprietary biobank of 65 HLA-homozygous ‘super donor’ stem cell lines designed to support standardized, off-the-shelf therapies across multiple therapeutic applications.
bottom of page